Projects per year
Search results
-
Active
辛伐他汀抗透明腎細胞癌的體內相關性，與結合促進代謝藥物的協同作用，經由mevalonate及LKB1/AMPK依賴性途徑(1/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Finished
辛伐他汀透過活化LKB1和ROS/AMPK的機制達到抗腎細胞癌的作用，與結合抑制代謝途徑藥物的協同作用
8/1/22 → 7/31/23
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Efficacy of Simvastatin in Renal Cell Carcinoma by Restraining Metabolic Reprogramming from Mtor, Ppar to Rhoa
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
辛伐他汀抗腎細胞癌的作用，經由抑制代謝重編程從mTOR、PPAR到RhoA(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Efficacy of Simvastatin in Renal Cell Carcinoma by Restraining Metabolic Reprogramming from Mtor, Ppar to Rhoa(1/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Mechanistic Studies of Renal Cell Carcinoma: from Rhoa-Mediated Expression of Cd44-Targeting Micrornas to the Development of Biomarkers and Therapies
8/1/18 → 10/1/19
Project: A - Government Institution › b - National Science and Technology Council
-
Mechanistic Studies of Renal Cell Carcinoma: from Rhoa-Mediated Expression of Cd44-Targeting Micrornas to the Development of Biomarkers and Therapies
8/1/17 → 7/31/18
Project: A - Government Institution › b - National Science and Technology Council
-
Mechanistic Studies of Renal Cell Carcinoma: from Rhoa-Mediated Expression of Cd44-Targeting Micrornas to the Development of Biomarkers and Therapies
8/1/16 → 7/31/17
Project: A - Government Institution › b - National Science and Technology Council
-
Novel Roles of Aryl-Hydrocarbon Receptor ((AhR) on Epigenetic and Post-Translational Modification of Cell-Cycle Regulatory Genes and Enos in Vascular Endothelial Cells---The Therapeutic Potential of Resveratrol/Statins
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
-
探討芳香烴受體(AhR)改變血管內皮細胞功能之新角色：經由表觀基因或後轉譯修飾(細胞週期蛋白/內皮細胞一氧化氮合成酉每)的調控與白蘆黎醇/史達汀臨床治療及應用(2/3)
8/1/14 → 7/31/15
Project: A - Government Institution › b - National Science and Technology Council
-
CD44和RhoA蛋白在腎細胞癌之角色並鑑別miRNAs對CD44的誘導作用之影響
6/1/14 → 5/31/16
Project: C - Project of Alliance › u - Taipei Medical University Shuang Ho Hospital
-
探討芳香烴受體(AhR)改變血管內皮細胞功能之新角色：經由表觀基因或後轉譯修飾(細胞週期蛋白/內皮細胞一氧化氮合成?)的調控與白蘆黎醇/史達汀臨床治療及應用(1/3)
8/1/13 → 7/31/14
Project: A - Government Institution › b - National Science and Technology Council
-
探討芳香烴受體(AhR)改變血管內皮細胞功能之新角色：經由後轉譯修飾細胞週期蛋白的調控與史達汀臨床治療及應用。
5/1/13 → 3/31/15
Project: C - Project of Alliance › u - Taipei Medical University Shuang Ho Hospital
-
Detrimental Effects of an Aryl-Hydrocarbon Receptor Agonist, 3mc, on Brain Vascular Integrity and Permeability, and the Therapeutic Intervention by Statin Derivatives.
8/1/12 → 9/30/13
Project: A - Government Institution › b - National Science and Technology Council
-
芳香烴碳水化合物協同劑(3MC)降低腦血管內皮細胞增生，經由表觀基因修飾，與使用史達汀衍生物的干預治療作用。
5/1/12 → 12/31/13
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
Detrimental Effects of an Aryl-Hydrocarbon Receptor Agonist, 3mc, on Brain Vascular Integrity and Permeability, and the Therapeutic Intervention by Statin Derivatives.
8/1/11 → 7/31/12
Project: A - Government Institution › b - National Science and Technology Council
-
Molecular Mechanisms of Anti-Angiogenic Effects of 3-Methylcholanthrene, an Aryl-Hydrocarbon Receptor Agonist, in Relation to Cell Proliferation, Adhesion and Migration of Endothelial Cells, and Its Therapeutic Intervention Using Resveratrol
8/1/10 → 7/31/11
Project: A - Government Institution › b - National Science and Technology Council